Elipovimab
id:
elipovimab-262-13149890
title:
Elipovimab
text:
Elipovimab is a first in class of effector-enhanced broadly neutralizing HIV-1 antibodies for the targeted elimination of HIV infected cells and is as of 2020 in phase 1b clinical testing, designed with the goal of reducing or eliminating the HIV reservoir in patients.
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/Elipovimab
date created:
date modified:
2020-11-29T08:48:45Z
main entity:
{"identifier":"Q85758989","url":"https://www.wikidata.org/entity/Q85758989"}
image:
fields total:
13
integrity:
13